Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

The Ministry of Public Health and the Lebanese Pediatric Society urge parents to get their Children Vaccinated against Measles

 
WHO and UNICEF call for collective actions to fight measles during outbreak
 
 
February 17, 2020 – The recent measles vaccination campaign launched back in December following the outbreak that has spread across Lebanon have many parents concerned. The Ministry of Public Health, along with the Lebanese Pediatric Society, WHO and UNICEF are very concerned about certain misconstrued comments expressed over the last few weeks by parents on social media and WhatsApp messages. These comments are found to be wrong and misleading, while the only way to protect the child against measles is the vaccination.
 
Since onset in early 2018, the measles outbreak has spread to all eight Lebanese governorates, counting more than 2,000 reported cases, most prominently among children less than 10 years of age.
 
“Choosing to not vaccinate your children during the campaign not only leaves them susceptible to measles, but also exposes other children to measles,” said Dr. Walid Amar, Director General of the Ministry of Public Health. “The Ministry of Public Health, with the support of the World Health Organization and UNICEF, provides safe and effective vaccines free of charge to children through trained teams of health workers in all institutions. We urge all parents to take advice from health professionals on health issues because health policies and practices are evidenced based and not based on rumors”.
 
Measles is a serious and highly contagious disease. If not prevented, measles can cause serious complications including meningitis, severe diarrhea and dehydration, pneumonia and ear infections and even death. Measles survivors are often left with life-long disabilities, such as blindness, deafness and brain damage.
 
“It is important to vaccinate your children during the campaign. The third additional dose of the measles containing vaccine is crucial for optimal immunity and it is safe,” explained Dr. Bizri, Head of National Certification Committee (NCC).  “The cold chain at the MoPH Central Drugs Warehouse and the primary health care facilities are of optimal quality and ensure safe storage of vaccines. Finally, it is important to note that MoPH provides free vaccines to some major private sector health facilities”.
 
“The measles vaccine is safe and effective.  A child to be better protected needs to receive at least two doses of Measles, and there is no harm in receiving an additional dose. There are no reasons children should still be dying of this disease,” added Dr. Majdalani, Head of Lebanese pediatric society.
 
“Immunizations can save a child’s life and vaccines are only given to children after a long and careful review by scientists, doctors, and healthcare professionals. The only way to halt the epidemic currently is to vaccinate all children, between the age of 6 months and 10 years. The Measles vaccine protects children against avoidable lifelong complications and potentially death. No child should be left behind” said Dr Shankiti, representative of WHO office in Lebanon
 
The measles vaccine is procured by UNICEF through its Global Supply Division who is responsible for buying all vaccines and related items for global campaigns to eradicate polio, eliminate neonatal and maternal tetanus, and control measles. All vaccines procured through UNICEF are WHO pre-qualified and follow strict safety standards and quality control. WHO and UNICEF promote vaccine security by working with manufacturers to ensure there is a reliable supply of quality, affordable vaccines, and with governments to assess their vaccine requirements.
 
“UNICEF has a key role in vaccine procurement and procuring immunization supplies on behalf of around 100 countries annually,” said Yukie Mokuo, UNICEF representative in Lebanon. “For the past 25 years UNICEF has brought quality vaccine to the Ministry of Public health to vaccinate all children in Lebanon. Parents and communities are urged to take part in the upcoming measles vaccination campaign to reach every child.”
 
WHO and UNICEF are working with the ministry of Public Health to support vaccine supply and cold chain management, on-the-ground coordination, operations support and monitoring. WHO and UNICEF are also working with the MOPH to ensure clear communication to mobilize the general public aiming to achieve high turnout of all children under 10 years old for vaccination.
 
Representatives from the Ministry of Public Health, WHO, UNICEF, the Lebanese Pediatric Society regional delagates and the heads of other medical societies, stressed during the meeting on the need for commitment and active participation in the campaign, and the need to urge parents and advise them to give their children the extra dose during the campaign regardless of previous doses and that the vaccines provided by the Ministry of Public Health are safe and effective and that the cold chain in its central warehouse and in primary health care centers are of ideal quality and are subject to safe storage conditions .
 
The second phase of the national immunization campaign will be launched in April 2020 targeting children aged between 6 months to less than 10 years old.  All children will also receive vaccination with bivalent Oral Polio Vaccine. Children will be reached in primary healthcare centers/dispensaries, schools, nurseries and private clinics, as well as in Informal settlements
 
ENDS
 
 
About WHO

WHO is the directing and coordinating authority for health within the United Nations. Our aim is to improve future health prospects for people everywhere. WHO works in coordination with its 194 Member States in six regions, through more than 150 country offices, with a single-minded commitment to improve universal health. Together, we aspire to fight communicable diseases such as influenza or HIV, and noncommunicable diseases such as cancer or heart disease. We help mothers and children to survive and prosper, so that they have every chance of reaching a healthy old age. We monitor the safety of air, food and water, and of medicines and vaccines too. Learn more about us at www.who.int
 
About UNICEF

UNICEF works in some of the world’s toughest places, to reach the world’s most disadvantaged children. Across more than 190 countries and territories, we work for every child, everywhere, to build a better world for everyone. For more information about UNICEF and our work in Lebanon visit https://www.unicef.org/lebanon/
 
Follow UNICEF Lebanon on Twitter, Facebook, Instagram and Youtube
 
 
For more information, please contact:

Ministry of Public Health
Dr. Randa Hamade, randa_ham@hotmail.com , T: +961 3 538 878
 
UNICEF
Blanche Baz, bbaz@unicef.org T. +961 03331874
 
WHO
Hala Habib, hhabib@who.int , T: +961 3870459
 
    3
    ...
ATC Name B/G Ingredients Dosage Form Price
L04AB02 REMICADE BioTech Infliximab - 100mg 100mg Injectable concentrated powder for solution 30,111,023 L.L
L04AB02 REMSIMA BioTech Infliximab - 100mg 100mg Injectable concentrated powder for solution 24,943,134 L.L
M02AA31 ROXONIN TAPE B Loxoprofen Sodium Hydrate - 100mg 100mg Patch 896,343 L.L
L01FA01 RITUXIREL BioTech Rituximab - 100mg 100mg/10ml Injectable concentrated solution L.L
L01FA01 RITUXIREL BioTech Rituximab - 100mg 100mg/10ml Injectable concentrated solution 11,708,063 L.L
L01FA01 RUXIENCE BioTech Rituximab - 100mg/10ml 100mg/10ml Injectable concentrate for solution 13,157,756 L.L
L01FA01 RIXATHON BioTech Rituximab - 100mg/10ml 100mg/10ml Injectable concentrate for solution 25,895,797 L.L
C10AA07 ROXARDIO G Rosuvastatin (calcium) - 10mg 10mg Tablet, film coated 682,094 L.L
C10AA07 ROVASTIN G Rosuvastatin (calcium) - 10mg 10mg Tablet 618,168 L.L
C10AA07 ROSUPHAR G Rosuvastatin (calcium) - 10mg 10mg Tablet, film coated 487,623 L.L
N02CC04 RIZATRIPTAN ARROW G Rizatriptan - 10mg 10mg Tablet 1,182,581 L.L
L04AX04 REVLIMID B Lenalidomide - 10mg 10mg Capsule 110,200,672 L.L
A02BC04 RABEC G Rabeprazole (sodium) - 10mg 10mg Tablet, film coated 212,327 L.L
A02BC04 RAMEP G Rabeprazole (sodium) - 10mg 10mg Tablet, gastroresistant 752,891 L.L
R06AX28 RUPATADINE BIOGARAN G Rupatadine - 10mg 10mg Tablet 341,336 L.L
C09AA05 RAMIPRIL-REMEDICA G Ramipril - 10mg 10mg Tablet 896,343 L.L
L04AX04 REVLIMID B Lenalidomide - 10mg 10mg Capsule L.L
N06BA04 RITALIN B Methylphenidate HCl - 10mg 10mg Tablet 376,276 L.L
B01AF01 RIXALTA 10 G Rivaroxaban - 10mg 10mg Tablet, film coated 671,921 L.L
B01AF01 RIBAVAN G Rivaroxaban - 10mg 10mg Tablet, film coated 959,888 L.L
R03DC03 ROMILAST G Montelukast (sodium) - 10mg 10mg Tablet, film coated 228,453 L.L
C10AA07 ROSUVAS G Rosuvastatin (calcium) - 10mg 10mg Tablet, film coated 450,187 L.L
R03DC03 RELIEFAST G Montelukast (sodium) - 10mg 10mg Tablet, film coated 844,701 L.L
C10AA07 ROSUCOR G Rosuvastatin (calcium) - 10mg 10mg Tablet, film coated 487,623 L.L
R06AE07 RINALGIT G Cetirizine (dihydrochloride) - 10mg/ml 10mg/ml Drops solution 237,860 L.L
L04AB02 REMSIMA SC BioTech Infliximab - 120mg/ml 120mg/ml Injectable solution 91,457,321 L.L
L04AB02 REMSIMA SC BioTech Infliximab - 120mg/ml 120mg/ml Injectable solution 179,063,666 L.L
L04AB02 REMSIMA SC BioTech Infliximab - 120mg/ml 120mg/ml Injectable solution 52,597,003 L.L
L04AB02 REMSIMA SC BioTech Infliximab - 120mg/ml 120mg/ml Injectable solution 179,063,666 L.L
L04AB02 REMSIMA SC BioTech Infliximab - 120mg/ml 120mg/ml Injectable solution 91,457,321 L.L
    3
    ...
Sitemap
© Copyrights reserved to Ministry of Public Health 2025